Literature DB >> 32319342

Thrombocytosis in an infant with a TRPV4 mutation: a case report.

Christopher S Thom1, Erik Brandsma1, Michele P Lambert2.   

Abstract

Mutations in the calcium channel gene Transient Receptor Potential cation channel subfamily V member 4 (TRPV4) cause autosomal dominant skeletal dysplasia, with phenotypes ranging from mild to perinatal lethality. A recent report detailed enhanced proplatelet formation and increased murine platelet count in the context of TRPV4 activation. No prior reports have described platelet count abnormalities in human TRPV4 disease. Here, we report a case of prolonged thrombocytosis in the context of TRPV4-associated metatropic dysplasia that was lethal in the infantile period.

Entities:  

Keywords:  Calcium channel; TRPV4; skeletal dysplasia; thrombocytosis

Mesh:

Substances:

Year:  2020        PMID: 32319342      PMCID: PMC7577995          DOI: 10.1080/09537104.2020.1755644

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  15 in total

1.  SIFT: Predicting amino acid changes that affect protein function.

Authors:  Pauline C Ng; Steven Henikoff
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

2.  Dominant TRPV4 mutations in nonlethal and lethal metatropic dysplasia.

Authors:  Natalia Camacho; Deborah Krakow; Sharlin Johnykutty; Philip J Katzman; Samuel Pepkowitz; Joris Vriens; Bernd Nilius; Brendan F Boyce; Daniel H Cohn
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

Review 3.  TRPV4 axonal neuropathy spectrum disorder.

Authors:  Meriel McEntagart
Journal:  J Clin Neurosci       Date:  2012-05-20       Impact factor: 1.961

4.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

5.  Cryo-EM and X-ray structures of TRPV4 reveal insight into ion permeation and gating mechanisms.

Authors:  Zengqin Deng; Navid Paknejad; Grigory Maksaev; Monica Sala-Rabanal; Colin G Nichols; Richard K Hite; Peng Yuan
Journal:  Nat Struct Mol Biol       Date:  2018-02-26       Impact factor: 15.369

Review 6.  Role of blood platelets in infection and inflammation.

Authors:  Matthias H F Klinger; Wolfgang Jelkmann
Journal:  J Interferon Cytokine Res       Date:  2002-09       Impact factor: 2.607

7.  Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C.

Authors:  Michaela Auer-Grumbach; Andrea Olschewski; Lea Papić; Hannie Kremer; Meriel E McEntagart; Sabine Uhrig; Carina Fischer; Eleonore Fröhlich; Zoltán Bálint; Bi Tang; Heimo Strohmaier; Hanns Lochmüller; Beate Schlotter-Weigel; Jan Senderek; Angelika Krebs; Katherine J Dick; Richard Petty; Cheryl Longman; Neil E Anderson; George W Padberg; Helenius J Schelhaas; Conny M A van Ravenswaaij-Arts; Thomas R Pieber; Andrew H Crosby; Christian Guelly
Journal:  Nat Genet       Date:  2009-12-27       Impact factor: 38.330

8.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

9.  A general framework for estimating the relative pathogenicity of human genetic variants.

Authors:  Martin Kircher; Daniela M Witten; Preti Jain; Brian J O'Roak; Gregory M Cooper; Jay Shendure
Journal:  Nat Genet       Date:  2014-02-02       Impact factor: 38.330

10.  A new path to platelet production through matrix sensing.

Authors:  Vittorio Abbonante; Christian Andrea Di Buduo; Cristian Gruppi; Carmelo De Maria; Elise Spedden; Aurora De Acutis; Cristian Staii; Mario Raspanti; Giovanni Vozzi; David L Kaplan; Francesco Moccia; Katya Ravid; Alessandra Balduini
Journal:  Haematologica       Date:  2017-04-14       Impact factor: 9.941

View more
  2 in total

1.  TRPV4 mutations causing mixed neuropathy and skeletal phenotypes result in severe gain of function.

Authors:  Arens Taga; Margo A Peyton; Benedikt Goretzki; Thomas Q Gallagher; Ann Ritter; Amy Harper; Thomas O Crawford; Ute A Hellmich; Charlotte J Sumner; Brett A McCray
Journal:  Ann Clin Transl Neurol       Date:  2022-02-16       Impact factor: 4.511

2.  Extreme thrombocytosis is associated with critical illness and young age, but not increased thrombotic risk, in hospitalized pediatric patients.

Authors:  Christopher S Thom; Emily Echevarria; Ashley D Osborne; Leah Carr; Kathryn M Rubey; Elizabeth Salazar; Danielle Callaway; Thomas Pawlowski; Matthew Devine; Stacey Kleinman; Char Witmer; John Flibotte; Michele P Lambert
Journal:  J Thromb Haemost       Date:  2020-10-21       Impact factor: 16.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.